Ml Bindroo Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 10.00 K
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 80.77%
- Ebitda 80.77%
- Net Worth -18.03%
- Total Assets 237.13%
About Ml Bindroo Pharma
Ml Bindroo Pharma Private Limited (MBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2019 (Five years and two months 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Stan & West Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Siddharth Bindroo and Vimi Makroo serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85190MH2019PTC332977
-
Company No.
332977
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ml Bindroo Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Bindroo
|
Director | 01-Aug-2023 | Current |
|
Vimi Makroo
|
Director | 07-Nov-2020 | Current |
Financial Performance of Ml Bindroo Pharma.
Ml Bindroo Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ml Bindroo Pharma?
Unlock access to Ml Bindroo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Mother Kashmir Handicrafts Private LimitedSiddharth Bindroo and Vimi Makroo are mutual person
-
Bain Physiotherapy Private Limited
Siddharth Bindroo and Vimi Makroo are mutual person
-
Alita Nutraceuticals (Opc) Private Limited
Vimi Makroo is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ml Bindroo Pharma?
Unlock and access historical data on people associated with Ml Bindroo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ml Bindroo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ml Bindroo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
